Medication abortion, a two-step process using mifepristone and misoprostol, constitutes over half of all US abortions and is increasingly vital due to abortion restrictions. Highly effective before ten weeks of pregnancy, mifepristone’s access has become fiercely contested since the overturning of Roe v. Wade. Recent legal challenges to the drug’s availability were dismissed by the Supreme Court due to the plaintiffs lacking legal standing. This ruling, however, does not guarantee continued nationwide access to the drug.
Read More
Dr. Margaret Carpenter, her company Nightingale Medical, and the mother of a minor are facing felony charges in Louisiana for allegedly procuring an abortion via mifepristone. The drug, mailed from New York to Louisiana, reportedly caused a medical emergency resulting in the termination of the minor’s pregnancy. This indictment marks a novel legal challenge following the overturning of Roe v. Wade, testing the limits of interstate abortion regulations. Prosecutors allege the actions constitute criminal abortion, highlighting the ongoing legal battles surrounding abortion access in the post-Roe era.
Read More
Judge Matthew Kacsmaryk ruled that Idaho, Kansas, and Missouri can proceed with a lawsuit aiming to restrict access to mifepristone. The states seek to limit telehealth prescriptions, shorten the gestational limit for use, and mandate in-person visits, arguing these measures are necessary to uphold state abortion laws. The ACLU criticized the decision, viewing it as an attack on medication abortion. This case follows a previous ruling by Kacsmaryk against mifepristone and comes amidst ongoing efforts by multiple states to further restrict access to abortion pills. The outcome could significantly impact abortion access nationwide.
Read More
A new lawsuit has been filed against the state of Louisiana, challenging a law that categorizes abortion medications as controlled dangerous substances. The state is the first to classify mifepristone and misoprostol, both used for medication abortions, as “Schedule IV” drugs alongside certain stimulants, sedatives, and opioids. Doctors in Louisiana require a special license to prescribe the medicines, and hospitals must store the pills securely. The suit, filed by a group of healthcare providers, reproductive rights advocates, and a doula practice, argues that this law creates barriers for healthcare workers who need to quickly administer these pills in emergencies. Critics of the legislation argue that it aims to limit access to abortions, rather than prevent misuse of the drugs.
Read More
I can hardly wrap my head around the recent arguments presented by the Missouri Attorney General regarding the abortion pill and its impact on teen pregnancies. To say they’re bizarre would be an understatement. The assertion that the availability of mifepristone will somehow harm the state by lowering teen pregnancies is a perplexing dive into a kind of logic that is hard to comprehend. It’s shocking to see a political figure arguing in favor of more pregnant teens as if that’s the solution to some ill-defined crisis. What are they thinking?
The argument seems to boil down to a starkly utilitarian view of women—they’re seen as vessels for reproduction rather than individuals with agency and rights.… Continue reading
John Q. Hosedrinker